The BEATRICE Study: Where Does Targeting Breast Cancer Vasculature Stand in ? - The ASCO Post - Beatrice trial breast cancer
- Views: 332 219
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. (9)Department of Obstetrics and Gynecology and Breast Cancer Center, eligible for the open-label randomized phase III BEATRICE trial had.